16 June 2014, RALEIGH, NC – PRA, a leading clinical research
organization, today announced that it has changed its name to PRA Health
Sciences (PRA). The name change to PRA Health Sciences is the
culmination of several strategic actions which support and enhance the
company’s commitment to the future of clinical development.
 |
| Colin Shannon - www.ColinShannon.pictures |
Starting over 18 months ago, PRA strategically strengthened its
coverage of China and created a joint venture with the leading clinical
development firm in China, forming WuXiPRA. PRA then bolstered its
capabilities in Russia and Eastern Europe by acquiring ClinStar, the
premier provider of CRO services in Russia and Eastern Europe. With the
subsequent acquisition of RPS, the pioneer of the Embedded Solutions™
model, PRA enhanced its ability to offer a more comprehensive breadth of
services across all segments of the biopharmaceutical industry. At the
close of 2013, PRA purchased CRI Lifetree, which augmented its existing
Phase I and bioanalytical capabilities, cementing PRA as the most
comprehensive, high-end Phase I organization in the world.
“The expansion of our global presence, the growth in our breadth of
services, and the deepening of our capabilities we initiated over the
last year-and-a-half enable us to better serve our clients,” said Colin
Shannon, president and CEO, PRA Health Sciences. “This change to our
name reflects our historical roots as a scientifically rich company, the
breadth and depth of our solutions, and most importantly, our
dedication to working with sponsors to bring new treatments to market
that will positively impact the lives of patients and their families.”
As one unified company with a broad range of specific expertise, PRA
is well-equipped and intently focused on working to improve the lives of
patients and providing innovative solutions that will drive the future
of clinical development.
In addition to the new name, PRA is introducing a new website more reflective of the company today.
ABOUT PRA HEALTH SCIENCES
 |
| PRA Health Sciences - www.PRAHS.com |
At PRA Health Sciences, providing innovative solutions for our
clients is what we do. Side-by-side with our clients, we strive to move
drug discovery forward, helping them to develop life-saving and
life-improving drugs. PRA has more than 10,000 employees working in 80+
countries providing comprehensive clinical development services across
all phases. From full service clinical development to the pioneering
Embedded SolutionsTM model, PRA provides a broad spectrum of solutions
that meet the demands of a diverse marketplace. As a top five CRO, we
have worked on 100+ marketed drugs across several therapeutic areas and
conducted the pivotal or supportive trials that led to FDA and/or
international regulatory approval of 45+ such drugs.
#ColinShannon #MrColinShannon #PRAhealthsciences @MrColinShannon
www.ColinShannon.info |
www.ColinShannon.today |
www.ColinShannon.pictures |
www.PRAHS.com
No comments:
Post a Comment